Creative Medical Technolo...

NASDAQ: CELZ · Real-Time Price · USD
3.05
-0.02 (-0.65%)
At close: Aug 15, 2025, 3:59 PM
3.12
2.30%
After-hours: Aug 15, 2025, 06:53 PM EDT

Creative Medical Technology Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-5.77M -6.09M -5.49M -5.32M -5.73M -5.28M -5.29M -9.82M -9.35M -10.04M -10.14M -7.8M -8.67M -9.78M 19.21M -15.53M -13.29M -12.23M
Depreciation & Amortization
113.23K 111.76K 110.45K 113.33K 107.08K 100.83K 94.58K 92.08K 92.08K 92.08K 92.08K 92.08K 92.08K 92.08K 92.08K 85.83K 79.58K 73.04K
Stock-Based Compensation
21.81K 30.97K 36.65K 36.65K 36.65K 36.65K 36.65K 36.65K 36.65K 36.55K 68.75K 271.35K 645.8K 636.74K 595.38K 485.69K 102.08K 102.08K
Other Working Capital
-50.98K 10.49K 84.54K 44.2K 71.93K 102.67K 2.93M 2.75M 2.71M 2.65M -320.1K 24.92K -81.73K -52.9K -148.15K 256.51K 353.43K 406.25K
Other Non-Cash Items
216.17K 172.35K 172.35K 247.03K 104.85K 169.07K 3.14M 173.51K 160.5K 108.88K -2.35M 2.95M 4.23M 6.81M -21.86M -24.09M -25.99M -26.99M
Deferred Income Tax
n/a n/a n/a -108.77K -138.94K -203.15K -3.17M -173.51K -143.34K -91.72K 2.88M -224.35K -519.47K -506.88K -506.88K 37.68M 37.98M 37.98M
Change in Working Capital
-271K -221.01K -127.26K -217K 56.48K 89.69K -2.84M -29.18K -69.57K -149.25K 2.19M -117.66K -156.71K -87.37K 249.47K 366.58K 340.46K 386.88K
Operating Cash Flow
-5.69M -6M -5.3M -5.25M -5.57M -5.08M -8.03M -9.72M -9.29M -10.06M -7.8M -5.37M -4.88M -3.35M -2.22M -997.46K -780.68K -680.75K
Capital Expenditures
-4 n/a 4.00 -100K -99.99K -99.99K -100K 3.00 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a -22.85M -24.93M -24.93M -24.93M -7.14M -10.08M -10.08M -10.08M -5.02M n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
-6.52M -6.52M n/a 26.4M 36.92M 36.93M 35.45M 9.05M 5.05M 5.04M n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
6.32M 6.32M 6.32M 4M -2.42M -6.97M -1.93M -4.67M -9.59M -5.04M -10.08M -4.82M n/a n/a n/a -450K -250K -250K
Investing Cash Flow
-200K -200K 6.32M 7.45M 9.47M 4.93M 3.45M -2.74M -9.58M -5.04M -10.08M -4.82M n/a n/a n/a -450K -250K -250K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 3.48M 3.48M 3.61M 3.86M 562.66K 683.56K
Common Stock Repurchased
139.51K 72.8K n/a -445.92K -612.25K -545.53K -462.73K -191.78K n/a n/a n/a -169.03K -169.03K -169.03K -169.03K n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -27.73K -27.73K -27.73K -27.73K n/a n/a n/a
Other Financial Acitivies
n/a 100.00 100.00 100.00 100.00 n/a n/a n/a 12.00 15.47M 15.47M 24.81M 24.14M 8.77M 8.8M -538.93K 127.59K 22K
Financial Cash Flow
4.96M 4.89M 1.45M -445.82K -612.15K -545.53K -462.73K -15.66M -15.47M n/a n/a 24.78M 27.59M 12.22M 12.84M 3.79M 1.15M 1.17M
Net Cash Flow
-927.36K -1.3M 2.47M 1.75M 3.48M -508.81K -4.85M -12.46M -18.87M 369.23K -2.4M 14.59M 22.71M 8.87M 10.63M 2.34M 121.57K 236.81K
Free Cash Flow
-5.69M -6M -5.3M -5.35M -5.67M -5.18M -8.13M -9.72M -9.29M -10.06M -7.8M -5.37M -4.88M -3.35M -2.22M -997.46K -780.68K -680.75K